Unexploited ways into the German market: why small is beautiful for medtech
This article was originally published in Clinica
Executive Summary
Changes to the way in which contracts are awarded for healthcare services in Germany are introducing a far greater element of flexibility. This offers an exciting new perspective, not only for payers and providers, but also for the medical device and pharmaceutical industries. These industries are only now starting to realise the potential opportunities of direct contracting, says Dr Thomas Seeger, managing director of Medalliance (Germany), who points out in this article how medtech companies can benefit